Min-kyu Park
Department of Clinical Pharmacology, Chungbuk National University Hospital · Chungbuk National University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Min-kyu Park as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:04 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06725992 · Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SRIl-Yang Pharm. Co., Ltd. · completed · Pharmacokinetics, Pharmacodynamics
- Ph1NCT06395155 · A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult VolunteersDaehwa Pharmaceutical Co., Ltd. · completed · Musculoskeletal Pain
- Ph1NCT05729074 · A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis PatientsHK inno.N Corporation · completed · Mild to Moderate Atopic Dermatitis · principal investigator
- Ph1NCT05282914 · A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy SubjectsKorea United Pharm. Inc. · completed · GERD
- Ph1NCT05198778 · A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal ImpairmentJW Pharmaceutical · completed · Healthy, Renal Impairment · principal investigator
- Ph1NCT04874142 · Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-AYooyoung Pharmaceutical Co., Ltd. · completed · Dyslipidemias
- Ph1NCT04874129 · Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506Yooyoung Pharmaceutical Co., Ltd. · unknown · Dyslipidemias
- Ph1NCT04631874 · A Clinical Trial to Compare Pharmacokinetics of the "CDFF0318" and "Champix Tab. 1mg"CTC Bio, Inc. · completed · Smoking Cessation, Pharmacokinetics · principal investigator
- Ph1NCT03438955 · Phase I Drug-drug Interaction of Omega-3 and AtorvastatinDongKoo Bio & Pharma · unknown · Hyperlipidemia, Hypertriglyceridemia
- Ph1NCT03382756 · A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337Chong Kun Dang Pharmaceutical · completed · Dyslipidemias
- Ph1NCT03034486 · The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930Chong Kun Dang Pharmaceutical · completed · Healthy
- Ph1NCT02645890 · Study to Compare the Safety and Pharmacokinetics of CKD-397Chong Kun Dang Pharmaceutical · completed · Benign Prostatic Hyperplasia
- Ph1NCT02625714 · Safety/Tolerability and Pharmacokinetic Study of SID142SK Chemicals Co., Ltd. · completed · Arterial Occlusive Diseases
- Ph1NCT02615782 · A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male SubjectsChong Kun Dang Pharmaceutical · completed · Benign Prostatic Hypertrophy (BPH)
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:04 UTC. The ranking covers the 200 most relevant of 507 PubMed records, and a shared surname and initials can bring in a namesake. All 507 on PubMed
- Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.BMJ · 2008858 citationsRCR 29.2
- 171 citationsRCR 17.0
- 169 citationsRCR 9.8
- Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?Eur Radiol · 2009167 citationsRCR 4.9
- Driving Pressure during Thoracic Surgery: A Randomized Clinical Trial.Anesthesiology · 2019156 citationsRCR 10.4
- Adjunctive high-dose glycine in the treatment of schizophrenia.Int J Neuropsychopharmacol · 2001134 citationsRCR 3.6
- Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.J Clin Oncol · 2007133 citationsRCR 3.0
- 132 citationsRCR 8.3
- Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis.Aliment Pharmacol Ther · 2019126 citationsRCR 8.2
- 108 citationsRCR 4.4